Longo Nancy S, Grundy Gabrielle J, Lee Jisoo, Gellert Martin, Lipsky Peter E
Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Diabetes andDigestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1560, USA.
J Immunol. 2008 Dec 1;181(11):7825-34. doi: 10.4049/jimmunol.181.11.7825.
V(H) replacement is a form of IgH chain receptor editing that is believed to be mediated by recombinase cleavage at cryptic recombination signal sequences (cRSS) embedded in V(H) genes. Whereas there are several reports of V(H) replacement in primary and transformed human B cells and murine models, it remains unclear whether V(H) replacement contributes to the normal human B cell repertoire. We identified V(H)-->V(H)(D)J(H) compound rearrangements from fetal liver, fetal bone marrow, and naive peripheral blood, all of which involved invading and recipient V(H)4 genes that contain a cryptic heptamer, a 13-bp spacer, and nonamer in the 5' portion of framework region 3. Surprisingly, all pseudohybrid joins lacked the molecular processing associated with typical V(H)(D)J(H) recombination or nonhomologous end joining. Although inefficient compared with a canonical recombination signal sequences, the V(H)4 cRSS was a significantly better substrate for in vitro RAG-mediated cleavage than the V(H)3 cRSS. It has been suggested that activation-induced cytidine deamination (AICDA) may contribute to V(H) replacement. However, we found similar secondary rearrangements using V(H)4 genes in AICDA-deficient human B cells. The data suggest that V(H)4 replacement in preimmune human B cells is mediated by an AICDA-independent mechanism resulting from inefficient but selective RAG activity.
V(H)替换是IgH链受体编辑的一种形式,据信它是由嵌入V(H)基因中的隐蔽重组信号序列(cRSS)处的重组酶切割介导的。虽然有几篇关于原代和转化的人B细胞及小鼠模型中V(H)替换的报道,但V(H)替换是否对正常人类B细胞库有贡献仍不清楚。我们从胎儿肝脏、胎儿骨髓和幼稚外周血中鉴定出V(H)-->V(H)(D)J(H)复合重排,所有这些重排都涉及侵入性和受体V(H)4基因,这些基因在框架区域3的5'部分含有一个隐蔽的七聚体、一个13bp的间隔区和九聚体。令人惊讶的是,所有假杂交连接都缺乏与典型V(H)(D)J(H)重组或非同源末端连接相关的分子加工。虽然与典型重组信号序列相比效率较低,但V(H)4 cRSS是体外RAG介导切割的比V(H)3 cRSS明显更好的底物。有人提出激活诱导的胞嘧啶脱氨酶(AICDA)可能有助于V(H)替换。然而,我们在AICDA缺陷的人B细胞中使用V(H)4基因发现了类似的二次重排。数据表明,免疫前人类B细胞中的V(H)4替换是由低效但有选择性的RAG活性导致的AICDA非依赖机制介导的。